Previous 10 | Next 10 |
SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021 at 11:00...
Last week was a terrible week for top growth stocks, as many of them with the highest expected sales growth were down big. Media fearmongering remains high with rising inflation, "pandemic-trade" unwind narratives and divergent investor goals diluting pundit viewpoints. We share d...
As earnings season kicks into gear and more economic data gets released this week, we could see some volatility in the markets. That's why investors should avoid stocks that have been recently downgraded to a Sell or Strong Sell by our POWR Ratings system. Accolade (ACCD), Borr Drilling (BORR...
Accolade, Inc. (ACCD) Q1 2022 Earnings Conference Call July 08, 2021, 04:30 PM ET Company Participants Todd Friedman - SVP, IR Rajeev Singh - CEO Steve Barnes - CFO Shantanu Nundy - Chief Medical Officer Conference Call Participants David Grossman - Stifel Michael Cherny - Bank of America Ric...
Image source: The Motley Fool. Accolade, Inc. (NASDAQ: ACCD) Q1 2022 Earnings Call Jul 08, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Accolade, Inc. (ACCD) Q1 2022 Earnings Call Transcript
Accolade (ACCD): Q1 GAAP EPS of -$0.84 misses by $0.47.Revenue of $59.5M (+65.7% Y/Y) beats by $3.72M.Press Release For further details see: Accolade EPS misses by $0.47, beats on revenue
Fiscal first quarter 2022 revenue of $59.5 million, a 66% increase compared to fiscal first quarter 2021 revenue of $35.9 million Company raises guidance for fiscal year 2022 to $300 million - $305 million, a 78% increase at the midpoint compared to fiscal year 2021 revenue of $17...
SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal first quarter 2022 financial results on Thursday, July 8, 2021, after the market close...
Accolade to begin offering virtual primary care and mental health consultations directly to members. $200bn+ combined total addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs. Combi...
Betsy Nabel and Jeff Brodsky join Accolade Board of Directors New board directors bring expertise in healthcare services, policy, and human resources PR Newswire SEATTLE , June 3, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company reinventing healthcar...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...